Filtrer efter Last updated date SelectEfterFørFrom - To Dato Slutdato Denne uge Denne måned Seneste uge Seneste måned Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Efterlad dette felt tomt Filter Resultater (3800) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Efterlad dette felt tomt Meeting highlights from the Committee for Medicinal Products for Human Use, 20-23 April 2009 23 april 2009Press releaseHuman Teva Pharma B.V. withdraws its marketing authorisation application for Clopidogrel Teva Pharma (clopidogrel hydrobromide) 23 april 2009Press release Committee for medicinal products for veterinary use: Meeting of 15-17 April 2009 20 april 2009Press releaseVeterinary European Medicines Agency, European Commission and Health Canada agree implementation plan for confidentiality arrangement 8 april 2009Press releaseMedicines European Medicines Agency makes recommendations on the use ofantimicrobials in livestock and companion animals in relation to the risk ofMRSA infection in animals 27 marts 2009Press releaseVeterinaryMedicines Bristol-Myers Squibb Pharma EEIG withdraws its marketing authorisation application for Ixempra 19 marts 2009Press release Meeting highlights from the Committee for Medicinal Products for Human Use,16-19 March 2009 19 marts 2009Press releaseHuman EMEA/IFAH Infoday: latest developments in scientific review, legislation and marketing authorisation procedures for veterinary medicines 18 marts 2009Press release Schering-Plough Europe withdraws its marketing authorisation application for Cylatron (peginterferon alfa-2b) 16 marts 2009Press release Meeting highlights from the Paediatric Committee: 4 - 6 March 2009 13 marts 2009Press releaseHumanPaediatrics 1 … 300 301 302 303 304 Page 304 of 380 305 306 307 308 … 380
Meeting highlights from the Committee for Medicinal Products for Human Use, 20-23 April 2009 23 april 2009Press releaseHuman
Teva Pharma B.V. withdraws its marketing authorisation application for Clopidogrel Teva Pharma (clopidogrel hydrobromide) 23 april 2009Press release
Committee for medicinal products for veterinary use: Meeting of 15-17 April 2009 20 april 2009Press releaseVeterinary
European Medicines Agency, European Commission and Health Canada agree implementation plan for confidentiality arrangement 8 april 2009Press releaseMedicines
European Medicines Agency makes recommendations on the use ofantimicrobials in livestock and companion animals in relation to the risk ofMRSA infection in animals 27 marts 2009Press releaseVeterinaryMedicines
Bristol-Myers Squibb Pharma EEIG withdraws its marketing authorisation application for Ixempra 19 marts 2009Press release
Meeting highlights from the Committee for Medicinal Products for Human Use,16-19 March 2009 19 marts 2009Press releaseHuman
EMEA/IFAH Infoday: latest developments in scientific review, legislation and marketing authorisation procedures for veterinary medicines 18 marts 2009Press release
Schering-Plough Europe withdraws its marketing authorisation application for Cylatron (peginterferon alfa-2b) 16 marts 2009Press release
Meeting highlights from the Paediatric Committee: 4 - 6 March 2009 13 marts 2009Press releaseHumanPaediatrics